For differential diagnosis within the subgroup of gliomas, patients with oligodendroglioma characterized by an IDH mutation and a 1p/19q co-deletion [1] frequently exhibit a considerably higher amino acid uptake than patients with IDH-mutant astrocytomas [37]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).